<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ma L</submitter><funding>National High Level Hospital Clinical Research Funding</funding><pagination>8053524</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9883100</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2023</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>To establish and evaluate the analytical and clinical performance of the Flash20 SARS-CoV-2 nucleic acid rapid detection system free of RNA extraction.&lt;h4>Methods&lt;/h4>The limit of detection (LoD) was determined using a negative nasopharyngeal swab matrix spiked with different concentrations of SARS-CoV-2 virus; a total of 734,337 reference sequences of viral genomes from GenBank were used for the in-silico analysis to assess the inclusivity of the assay. The specificity of the system was evaluated by testing 27 medically relevant organisms. A total of 115 clinical specimens were collected and tested on the Flash20 SARS-CoV-2 detection system and with an FDA-approved comparator test to assess the clinical performance of the system.&lt;h4>Results&lt;/h4>The LoD of the Flash20 SA</pubmed_abstract><journal>International journal of analytical chemistry</journal><pubmed_title>Fast and Sensitive Detection of SARS-CoV-2 Nucleic Acid Using a Rapid Detection System Free of RNA Extraction.</pubmed_title><pmcid>PMC9883100</pmcid><funding_grant_id>2020</funding_grant_id><funding_grant_id>ZRJY2021-GG03</funding_grant_id><funding_grant_id>82074221</funding_grant_id><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Zhao M</pubmed_authors><pubmed_authors>Gao P</pubmed_authors><pubmed_authors>Ma L</pubmed_authors><pubmed_authors>Fan Y</pubmed_authors><pubmed_authors>Cui Y</pubmed_authors><pubmed_authors>Huang H</pubmed_authors><pubmed_authors>Cao Y</pubmed_authors><pubmed_authors>Kong X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Fast and Sensitive Detection of SARS-CoV-2 Nucleic Acid Using a Rapid Detection System Free of RNA Extraction.</name><description>&lt;h4>Objectives&lt;/h4>To establish and evaluate the analytical and clinical performance of the Flash20 SARS-CoV-2 nucleic acid rapid detection system free of RNA extraction.&lt;h4>Methods&lt;/h4>The limit of detection (LoD) was determined using a negative nasopharyngeal swab matrix spiked with different concentrations of SARS-CoV-2 virus; a total of 734,337 reference sequences of viral genomes from GenBank were used for the in-silico analysis to assess the inclusivity of the assay. The specificity of the system was evaluated by testing 27 medically relevant organisms. A total of 115 clinical specimens were collected and tested on the Flash20 SARS-CoV-2 detection system and with an FDA-approved comparator test to assess the clinical performance of the system.&lt;h4>Results&lt;/h4>The LoD of the Flash20 SA</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2026-07-15T22:31:28.167Z</modification><creation>2025-04-06T14:11:36.339Z</creation></dates><accession>S-EPMC9883100</accession><cross_references><pubmed>36714173</pubmed><doi>10.1155/2023/8053524</doi></cross_references></HashMap>